✅ New API: 6000+ US Stock Options End-of-Day Data with 40+ fields. Learn more

Nectar Lifesciences Limited (NECLIFE NSE) stock market data APIs

INR16.4372 0(0%)
as of September 18, 2025
Try our APIs with free plan!

Nectar Lifesciences Limited Financial Data Overview

Price chart is built with Anychart
ISIN: INE023H0**** The data is available with plans that include the Fundamentals API. Check our pricing page for details.

Nectar Lifesciences Limited manufactures, distributes, markets and sells pharmaceutical products in India and internationally. The company offers cephalosporins, includes pharmaceutical ingredients and intermediates comprising cefixime, cefuroxime axetil amorphous, cefuroxime axetil crystalline, cefotaxime sodium, ceftriaxone sodium, cefixime trihydrate, cefuroxime axetil, cefpodoxime proxetil and sterile, cefprozil, cefdinir, cefuroxime sodium, cefazolin sodium, ceftazidime pentahydrate, and cefepime +Arginine. The company also offers contract manufacturing for finished dosage forms, such as tablets, capsules, dry powder oral suspensions, and granules and injectable for cephalosporins. In addition, the company provides menthol and pearl capsules. Nectar Lifesciences Limited was incorporated in 1995 and is headquartered in Chandigarh, India.

Prev. Close 16.4372
Open 16.4372
High 16.4372
Low 16.4372
52 wk Range 13.05-48.24
Market Cap 3 743 M
Shares Outstanding 224 M
Revenue 15 918 M
EPS 0.17
Beta 0.58

* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.


Why to choose EODHD?

Prices start at $19.99

24/7 Live support

Robust, powerful and reliable data

API Simplicity of a few lines of code


Try our APIs
with free plan!

Or get access to advanced financial data starting only $19.99

TRY NOW

Get Nectar Lifesciences Limited data using free add-ons & libraries


Get Nectar Lifesciences Limited Fundamental Data

Nectar Lifesciences Limited Fundamental data includes:

  • Net Revenue: 15 918 M
  • EBITDA: -1 287 914 496
  • Earnings Per Share:
  • Income Statements
  • Balance Sheets
  • Cash flows

Plans with Fundamental data

Starting from

$ 59.99 /mo.
COMPARE PLANS

End-of-day & Earnings data

Get Nectar Lifesciences Limited Earnings data

Calendar & News package for

$ 19.99 /mo.

What’s included:

  • Latest Release: 2018-05-28
  • EPS/Forecast: 0.9
GET THE PACKAGE

Get Nectar Lifesciences Limited End-of-day data

EOD Historical Data package for

$ 19.99 /mo.

What’s included:

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
GET THE PACKAGE
Try our APIs
with free plan!

Or get access to advanced financial data starting only $19.99

TRY NOW
  • Flexibility: No long-term commitments, just a minimum of one month
  • Instant access: Get your API key and instructions within seconds of subscribing
  • Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.

What’s included:

  • API Calls per Day: 100 000/day
  • API Requests per Min.: 1000/minute
  • Type of Usage: Personal use

Data access:

Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.

GET THE PACKAGE
Chat